Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.

Diener HC, Goadsby PJ, Ashina M, Al-Karagholi MA, Sinclair A, Mitsikostas D, Magis D, Pozo-Rosich P, Sieira PI, Làinez MJ, Gaul C, Silver N, Hoffmann J, Marin J, Liebler E, Ferrari MD; PREMIUM Study Group.

Cephalalgia. 2019 Sep 15:333102419876920. doi: 10.1177/0333102419876920. [Epub ahead of print]

PMID:
31522546
2.

Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysis.

de Coo IF, Marin JC, Silberstein SD, Friedman DI, Gaul C, McClure CK, Tyagi A, Liebler E, Tepper SJ, Ferrari MD, Goadsby PJ.

Cephalalgia. 2019 Jul;39(8):967-977. doi: 10.1177/0333102419856607. Epub 2019 Jun 10.

3.

Impact of molecular quadrupole moments on the energy levels at organic heterojunctions.

Schwarze M, Schellhammer KS, Ortstein K, Benduhn J, Gaul C, Hinderhofer A, Perdigón Toro L, Scholz R, Kublitski J, Roland S, Lau M, Poelking C, Andrienko D, Cuniberti G, Schreiber F, Neher D, Vandewal K, Ortmann F, Leo K.

Nat Commun. 2019 Jun 5;10(1):2466. doi: 10.1038/s41467-019-10435-2.

4.

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.

Goadsby PJ, Wietecha LA, Dennehy EB, Kuca B, Case MG, Aurora SK, Gaul C.

Brain. 2019 Jul 1;142(7):1894-1904. doi: 10.1093/brain/awz134.

5.

An Integrative Cognitive Behavioral Therapy Program for Adults With Migraine: A Feasibility Study.

Klan T, Liesering-Latta E, Gaul C, Martin PR, Witthöft M.

Headache. 2019 May;59(5):741-755. doi: 10.1111/head.13532. Epub 2019 Apr 10.

PMID:
30970172
6.

[Headache - an Update 2018].

Diener HC, Gaul C, Holle-Lee D, Jürgens TP, Kraya T, Kurth T, Nägel S, Neeb L, Straube A.

Laryngorhinootologie. 2019 Mar;98(3):192-217. doi: 10.1055/a-0823-4814. Epub 2019 Mar 7. German.

PMID:
30847888
7.

An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study.

Ahmed F, Gaul C, García-Moncó JC, Sommer K, Martelletti P; REPOSE Principal Investigators.

J Headache Pain. 2019 Mar 7;20(1):26. doi: 10.1186/s10194-019-0976-1.

8.

Molecular parameters responsible for thermally activated transport in doped organic semiconductors.

Schwarze M, Gaul C, Scholz R, Bussolotti F, Hofacker A, Schellhammer KS, Nell B, Naab BD, Bao Z, Spoltore D, Vandewal K, Widmer J, Kera S, Ueno N, Ortmann F, Leo K.

Nat Mater. 2019 Mar;18(3):242-248. doi: 10.1038/s41563-018-0277-0. Epub 2019 Jan 28.

PMID:
30692647
9.

Topical Ambroxol 20% for the Treatment of Classical Trigeminal Neuralgia - A New Option? Initial Clinical Case Observations.

Kern KU, Schwickert-Nieswandt M, Maihöfner C, Gaul C.

Headache. 2019 Mar;59(3):418-429. doi: 10.1111/head.13475. Epub 2019 Jan 17.

PMID:
30653673
10.

Distribution of migraine attacks over the days of the week: Preliminary results from a web-based questionnaire.

Drescher J, Wogenstein F, Gaul C, Kropp P, Reinel D, Siebenhaar Y, Scheidt J.

Acta Neurol Scand. 2019 Apr;139(4):340-345. doi: 10.1111/ane.13065. Epub 2019 Jan 28.

PMID:
30636039
11.

Effects of hydration status during heat acclimation on plasma volume and performance.

Pethick WA, Murray HJ, McFadyen P, Brodie R, Gaul CA, Stellingwerff T.

Scand J Med Sci Sports. 2019 Feb;29(2):189-199. doi: 10.1111/sms.13319. Epub 2018 Oct 30.

PMID:
30317666
12.

Initiatives aimed at retaining ethnically diverse student nurses in undergraduate programmes: An integrative review.

Tranter S, Gaul C, McKenzie S, Graham K.

J Clin Nurs. 2018 Nov;27(21-22):3846-3857. doi: 10.1111/jocn.14609. Epub 2018 Jul 27. Review.

PMID:
29969832
13.

[Treatment of chronic migraine with botulinum neurotoxin A : Expert recommendations of the German Migraine and Headache Society].

Ruscheweyh R, Förderreuther S, Gaul C, Gendolla A, Holle-Lee D, Jürgens T, Neeb L, Straube A.

Nervenarzt. 2018 Dec;89(12):1355-1364. doi: 10.1007/s00115-018-0534-0. Review. German.

PMID:
29947936
14.

Chronic Headache Due to Overuse of Analgesics and Anti-Migraine Agents.

Diener HC, Holle D, Dresler T, Gaul C.

Dtsch Arztebl Int. 2018 Jun 1;115(22):365-370. doi: 10.3238/arztebl.2018.0365. Review.

15.

Changes in medication cost observed in chronic cluster headache patients treated with sphenopalatine ganglion (SPG) stimulation: Analysis based on 1-year data from the Pathway R-1 Registry.

Pietzsch JB, Weber SA, Lund N, Gaul C.

Cephalalgia. 2018 Jul;38(8):1455-1462. doi: 10.1177/0333102418784689. Epub 2018 Jun 19.

PMID:
29921140
16.

[How to identify symptomatic headaches?]

Mylius V, Teepker M, Gaul C.

MMW Fortschr Med. 2018 May;160(10):60-63. doi: 10.1007/s15006-018-0584-z. Review. German. No abstract available.

PMID:
29855900
17.

Insight into doping efficiency of organic semiconductors from the analysis of the density of states in n-doped C60 and ZnPc.

Gaul C, Hutsch S, Schwarze M, Schellhammer KS, Bussolotti F, Kera S, Cuniberti G, Leo K, Ortmann F.

Nat Mater. 2018 May;17(5):439-444. doi: 10.1038/s41563-018-0030-8. Epub 2018 Feb 26.

PMID:
29483635
18.

Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study.

Goadsby PJ, de Coo IF, Silver N, Tyagi A, Ahmed F, Gaul C, Jensen RH, Diener HC, Solbach K, Straube A, Liebler E, Marin JC, Ferrari MD; ACT2 Study Group.

Cephalalgia. 2018 Apr;38(5):959-969. doi: 10.1177/0333102417744362. Epub 2017 Dec 12.

19.

Prevalence of Headache in Patients With Mitochondrial Disease: A Cross-Sectional Study.

Kraya T, Deschauer M, Joshi PR, Zierz S, Gaul C.

Headache. 2018 Jan;58(1):45-52. doi: 10.1111/head.13219. Epub 2017 Nov 15. Erratum in: Headache. 2018 Feb;58(2):358.

PMID:
29139113
20.

Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data.

Davies B, Gaul C, Martelletti P, García-Moncó JC, Brown S.

J Headache Pain. 2017 Sep 6;18(1):93. doi: 10.1186/s10194-017-0802-6.

21.

[Headache News].

Diener HC, Gaul C, Holle-Lee D, Lazaridis L, Nägel S, Obermann M.

Fortschr Neurol Psychiatr. 2017 Jun;85(6):352-365. doi: 10.1055/s-0043-111118. Epub 2017 Jun 23. Review. German.

PMID:
28645128
22.

Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region.

Fairhurst RA, Knoepfel T, Leblanc C, Buschmann N, Gaul C, Blank J, Galuba I, Trappe J, Zou C, Voshol J, Genick C, Brunet-Lefeuvre P, Bitsch F, Graus-Porta D, Furet P.

Medchemcomm. 2017 Jun 8;8(8):1604-1613. doi: 10.1039/c7md00213k. eCollection 2017 Aug 1.

23.

[Therapy of migranes].

Holle-Lee D, Nägel S, Gaul C.

Nervenarzt. 2017 Aug;88(8):929-941. doi: 10.1007/s00115-017-0338-7. Review. German.

PMID:
28497257
24.

Persistent idiopathic facial pain.

Benoliel R, Gaul C.

Cephalalgia. 2017 Jun;37(7):680-691. doi: 10.1177/0333102417706349. Epub 2017 Apr 20. Review.

PMID:
28425324
25.

[Relaxation techniques and behavioural therapy for the treatment of migraine : Guidelines from the German Migraine and Headache Society].

Kropp P, Meyer B, Dresler T, Fritsche G, Gaul C, Niederberger U, Förderreuther S, Malzacher V, Jürgens TP, Marziniak M, Straube A.

Schmerz. 2017 Oct;31(5):433-447. doi: 10.1007/s00482-017-0214-1. German.

PMID:
28364171
26.

Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach.

Möbitz H, Machauer R, Holzer P, Vaupel A, Stauffer F, Ragot C, Caravatti G, Scheufler C, Fernandez C, Hommel U, Tiedt R, Beyer KS, Chen C, Zhu H, Gaul C.

ACS Med Chem Lett. 2017 Feb 14;8(3):338-343. doi: 10.1021/acsmedchemlett.6b00519. eCollection 2017 Mar 9.

27.

[Headache Treatment].

Diener HC, Holle-Lee D, Nägel S, Gaul C.

Dtsch Med Wochenschr. 2017 Mar;142(6):418-426. doi: 10.1055/s-0042-121336. Epub 2017 Mar 22. Review. German.

PMID:
28329903
28.

[Pathophysiology of Headaches].

Gaul C, Meßlinger K, Holle-Lee D, Neeb L.

Dtsch Med Wochenschr. 2017 Mar;142(6):402-408. doi: 10.1055/s-0042-111694. Epub 2017 Mar 22. German.

PMID:
28329901
29.
30.

Preseason Functional Movement Screen Predicts Risk of Time-Loss Injury in Experienced Male Rugby Union Athletes.

Duke SR, Martin SE, Gaul CA.

J Strength Cond Res. 2017 Oct;31(10):2740-2747. doi: 10.1519/JSC.0000000000001838.

PMID:
28195971
31.

No Pattern Alteration in Single Nocturnal Melatonin Secretion in Patients With Hypnic Headache: A Case-Control Study.

Naegel S, Huhn JI, Gaul C, Diener HC, Obermann M, Holle D.

Headache. 2017 Apr;57(4):648-653. doi: 10.1111/head.12983. Epub 2016 Nov 21.

PMID:
27868193
32.

Medication-overuse headache: risk factors, pathophysiology and management.

Diener HC, Holle D, Solbach K, Gaul C.

Nat Rev Neurol. 2016 Oct;12(10):575-83. doi: 10.1038/nrneurol.2016.124. Epub 2016 Sep 12. Review.

PMID:
27615418
33.

Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach.

Chen C, Zhu H, Stauffer F, Caravatti G, Vollmer S, Machauer R, Holzer P, Möbitz H, Scheufler C, Klumpp M, Tiedt R, Beyer KS, Calkins K, Guthy D, Kiffe M, Zhang J, Gaul C.

ACS Med Chem Lett. 2016 Jun 1;7(8):735-40. doi: 10.1021/acsmedchemlett.6b00167. eCollection 2016 Aug 11.

34.

Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding Pocket.

Scheufler C, Möbitz H, Gaul C, Ragot C, Be C, Fernández C, Beyer KS, Tiedt R, Stauffer F.

ACS Med Chem Lett. 2016 Jun 6;7(8):730-4. doi: 10.1021/acsmedchemlett.6b00168. eCollection 2016 Aug 11.

35.

Cluster headache attack remission with sphenopalatine ganglion stimulation: experiences in chronic cluster headache patients through 24 months.

Barloese MC, Jürgens TP, May A, Lainez JM, Schoenen J, Gaul C, Goodman AM, Caparso A, Jensen RH.

J Headache Pain. 2016 Dec;17(1):67. doi: 10.1186/s10194-016-0658-1. Epub 2016 Jul 26.

36.
37.

Resonant Rydberg Dressing of Alkaline-Earth Atoms via Electromagnetically Induced Transparency.

Gaul C, DeSalvo BJ, Aman JA, Dunning FB, Killian TC, Pohl T.

Phys Rev Lett. 2016 Jun 17;116(24):243001. doi: 10.1103/PhysRevLett.116.243001. Epub 2016 Jun 17.

PMID:
27367387
38.

'And so I took up residence': The experiences of family members of people with dementia during admission to an acute hospital unit.

de Vries K, Drury-Ruddlesden J, Gaul C.

Dementia (London). 2019 Jan;18(1):36-54. doi: 10.1177/1471301216656097. Epub 2016 Jul 26.

39.

Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: A prospective observational study.

Gaul C, Roguski J, Dresler T, Abbas H, Totzeck A, Görlinger K, Diener HC, Weber R.

Cephalalgia. 2017 Aug;37(9):873-880. doi: 10.1177/0333102416654886. Epub 2016 Jun 16.

PMID:
27313215
40.

[Botulinum toxin type A in headache treatment : Established and experimental indications].

Gaul C, Holle-Lee D, Straube A.

Nervenarzt. 2016 Aug;87(8):853-9. doi: 10.1007/s00115-016-0138-5. German.

PMID:
27300190
41.

The Effect of Lipoaspirates on Human Keratinocytes.

Kim BS, Gaul C, Paul NE, Dewor M, Stromps JP, Hwang SS, Nourbakhsh M, Bernhagen J, Rennekampff HO, Pallua N.

Aesthet Surg J. 2016 Sep;36(8):941-51. doi: 10.1093/asj/sjw049. Epub 2016 May 31.

PMID:
27246228
42.

[Pain - a neglected neurological issue].

Birklein F, Baron R, Gaul C, Maihöfner C, Rommel O, Straube A, Tölle T, Wasner G.

Nervenarzt. 2016 Jun;87(6):609-15. doi: 10.1007/s00115-016-0113-1. Review. German.

PMID:
27167885
43.

Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache.

Jürgens TP, Barloese M, May A, Láinez JM, Schoenen J, Gaul C, Goodman AM, Caparso A, Jensen RH.

Cephalalgia. 2017 Apr;37(5):423-434. doi: 10.1177/0333102416649092. Epub 2016 May 9. Erratum in: Cephalalgia. 2016 Sep 1;:.

44.

Noninvasive vagus nerve stimulation in the management of cluster headache: clinical evidence and practical experience.

Holle-Lee D, Gaul C.

Ther Adv Neurol Disord. 2016 May;9(3):230-4. doi: 10.1177/1756285616636024. Epub 2016 Mar 2. Review.

45.

Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headache.

Morris J, Straube A, Diener HC, Ahmed F, Silver N, Walker S, Liebler E, Gaul C.

J Headache Pain. 2016;17:43. doi: 10.1186/s10194-016-0633-x. Epub 2016 Apr 22.

46.

[Role of the vagal nerve in the pathophysiology and therapy of headache].

Straube A, Eren O, Gaul C.

MMW Fortschr Med. 2016 Mar 31;158(6):74-6. doi: 10.1007/s15006-016-8010-x. Review. German. No abstract available.

PMID:
27084169
47.

Fall risk screening in the elderly: A comparison of the minimal chair height standing ability test and 5-repetition sit-to-stand test.

Reider N, Gaul C.

Arch Gerontol Geriatr. 2016 Jul-Aug;65:133-9. doi: 10.1016/j.archger.2016.03.004. Epub 2016 Mar 15.

PMID:
27018571
48.

[Clinical diagnostics and imaging in headache disorders].

Gaul C, Holle-Lee D.

Med Monatsschr Pharm. 2015 Nov;38(11):432-8. Review. German.

PMID:
26742209
49.

Integrated multidisciplinary care of headache disorders: A narrative review.

Gaul C, Liesering-Latta E, Schäfer B, Fritsche G, Holle D.

Cephalalgia. 2016 Oct;36(12):1181-1191. doi: 10.1177/0333102415617413. Epub 2016 Jul 11. Review.

PMID:
26646785
50.

Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options.

Diener HC, Solbach K, Holle D, Gaul C.

Clin Med (Lond). 2015 Aug;15(4):344-50. doi: 10.7861/clinmedicine.15-4-344. Review.

Supplemental Content

Support Center